Journal of Cardiovascular Translational Research

Scope & Guideline

Unveiling Breakthroughs in Cardiovascular Research and Treatment

Introduction

Welcome to the Journal of Cardiovascular Translational Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Cardiovascular Translational Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1937-5387
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationJ CARDIOVASC TRANSL / J. Cardiovasc. Transl. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The Journal of Cardiovascular Translational Research focuses on bridging the gap between basic cardiovascular research and clinical applications. The journal aims to publish innovative findings that contribute to the understanding, diagnosis, treatment, and prevention of cardiovascular diseases. It emphasizes translational research that moves discoveries from the laboratory to the bedside.
  1. Translational Research in Cardiovascular Medicine:
    The journal prioritizes studies that translate laboratory findings into clinical practice, enhancing understanding of cardiovascular pathophysiology and treatment.
  2. Innovative Therapeutic Strategies:
    Research on novel therapeutic approaches, including pharmacological interventions, surgical techniques, and device development, is a core focus.
  3. Biomarkers and Diagnostics:
    The journal explores the identification and validation of biomarkers for cardiovascular diseases, facilitating early diagnosis and personalized treatment.
  4. Advanced Imaging and Computational Modeling:
    Papers utilizing advanced imaging techniques and computational modeling to study cardiovascular function and disease progression are frequently published.
  5. Pathophysiology of Cardiovascular Diseases:
    The journal covers research on the underlying mechanisms of cardiovascular diseases, including genetic, metabolic, and inflammatory pathways.
  6. Patient-Centric Studies:
    Clinical trials and studies that assess patient outcomes, quality of life, and healthcare delivery related to cardiovascular conditions are emphasized.
Recent publications in the Journal of Cardiovascular Translational Research indicate several emerging themes and trends that are shaping the future of cardiovascular research. These areas reflect the evolving landscape of the field and the journal's commitment to addressing contemporary challenges in cardiovascular medicine.
  1. Extracellular Vesicles and Non-Coding RNAs:
    Research on the role of extracellular vesicles and non-coding RNAs in cardiovascular diseases is gaining traction, highlighting their potential as biomarkers and therapeutic targets.
  2. Machine Learning and Artificial Intelligence Applications:
    The integration of machine learning and AI in analyzing cardiovascular data is a rapidly growing area, facilitating improved diagnostic accuracy and patient management.
  3. Metabolic Reprogramming and Cardiovascular Health:
    Studies exploring metabolic pathways and their impact on cardiovascular diseases are increasingly relevant, linking metabolism with heart function and disease progression.
  4. Personalized Medicine and Genomics:
    There is a growing emphasis on personalized medicine approaches, utilizing genomic information to tailor treatments for individuals with cardiovascular diseases.
  5. Immunomodulation in Cardiovascular Therapy:
    Research focusing on the role of the immune system in cardiovascular health and disease is emerging, including studies on immunotherapies and inflammatory pathways.
  6. Digital Health Technologies:
    The application of digital health technologies, including telemedicine and wearable devices, is gaining prominence, reflecting the shift towards more patient-centered care.

Declining or Waning

While the Journal of Cardiovascular Translational Research has experienced growth in several areas, some themes appear to be declining in frequency or prominence. This section highlights those waning research areas that may reflect shifts in focus within the cardiovascular research community.
  1. Traditional Pharmacological Approaches:
    There appears to be a decline in studies focused solely on traditional pharmacological treatments, as the field shifts towards more integrated and innovative therapeutic strategies.
  2. Basic Animal Model Studies without Translational Relevance:
    Research that does not bridge basic science with clinical implications is becoming less common, with a preference for studies that demonstrate direct translational potential.
  3. Epidemiological Studies with Limited Clinical Application:
    While epidemiological research remains important, studies that do not connect findings to actionable clinical insights or therapeutic developments are less frequently published.
  4. Isolated Mechanistic Studies:
    There is a noticeable reduction in the publication of studies that focus exclusively on isolated mechanisms without a broader translational application to cardiovascular health or disease.

Similar Journals

Radiology-Cardiothoracic Imaging

Unveiling New Perspectives in Radiology
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-6135Frequency: 6 issues/year

Radiology-Cardiothoracic Imaging, published by the Radiological Society of North America (RSNA), is a leading peer-reviewed journal dedicated to advancing knowledge in the field of cardiothoracic radiology. With an ISSN of 2638-6135 and a remarkable 2023 Scopus ranking of #5 out of 333 in its category, the journal stands out in the Q1 tier for Radiology, Nuclear Medicine, and Imaging, showcasing its significant impact and high-quality research contributions. The journal is committed to providing an open platform for innovative research, insightful reviews, and clinical studies that address the complexities of cardiothoracic imaging, thereby facilitating the enhancement of diagnostic and therapeutic strategies. Operating out of Oak Brook, Illinois, the journal aims to engage a diverse audience of researchers, professionals, and students, fostering collaboration and knowledge exchange within this vital area of radiological science. With a convergence of years extending from 2019 to 2024, Radiology-Cardiothoracic Imaging remains at the forefront of emerging trends and findings, making it an essential resource for anyone passionate about the evolving landscape of cardiothoracic imaging.

Cardiovascular Innovations and Applications

Unlocking new horizons in cardiovascular health and treatment.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Acta Cardiologica Sinica

Empowering the Global Cardiovascular Community.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

HYPERTENSION RESEARCH

Exploring innovative strategies in hypertension management.
Publisher: SPRINGERNATUREISSN: 0916-9636Frequency: 12 issues/year

HYPERTENSION RESEARCH, published by SpringerNature, serves as a premier platform in the field of Cardiology and Cardiovascular Medicine, Internal Medicine, and Physiology. Since its inception in 1992, the journal has built a substantial reputation, currently ranked in the second quartile (Q2) across several categories in 2023, reflecting its influence and high-quality contributions to medical research. With a focus on hypertension, the journal aims to disseminate vital research findings, clinical studies, and innovative treatment strategies to a diverse audience of researchers, healthcare professionals, and students, fostering knowledge exchange in the management of hypertensive conditions. Although it is not an Open Access journal, it offers comprehensive access to its extensive archive of valuable resources, ensuring that critical advancements in the understanding of hypertension are both accessible and impactful. HYPERTENSION RESEARCH is not only essential for those directly involved in cardiovascular and internal medicine practices but also for interdisciplinary scholars who are looking to explore the intersections of physiology and other biomedical fields in their work.

Open Cardiovascular Medicine Journal

Elevating the Standards of Cardiovascular Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: Frequency: 1 issue/year

Open Cardiovascular Medicine Journal is a notable scholarly platform published by Bentham Science Publishers Ltd, dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. With an E-ISSN of 1874-1924, this open-access journal has been a beacon for researchers and clinicians alike since its inception in 2009. Acting as a conduit for the latest research findings, the journal fosters interdisciplinary collaboration and innovation, contributing to the overall progress in cardiovascular health. Although currently ranked in the 26th percentile among cardiology journals, it emphasizes high-quality, peer-reviewed articles that uphold the rigorous standards of academic integrity. The journal also benefits from a robust editorial team and an array of publication options, ensuring accessibility and visibility of crucial cardiovascular research. As it continues its journey through 2023 and beyond, Open Cardiovascular Medicine Journal remains essential for anyone invested in the challenges and advancements within the cardiovascular domain.

JOURNAL OF CLINICAL INVESTIGATION

Elevating clinical investigation through rigorous scholarship.
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: 0021-9738Frequency: 12 issues/year

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

Journal of the Practice of Cardiovascular Sciences

Shaping the Future of Cardiovascular Health Through Open Access
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

TRENDS IN CARDIOVASCULAR MEDICINE

Exploring Innovative Pathways in Cardiology
Publisher: ELSEVIER SCIENCE LONDONISSN: 1050-1738Frequency: 8 issues/year

TRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.

Cardiovascular Diagnosis and Therapy

Bridging Research and Practice in Cardiovascular Medicine
Publisher: AME PUBLISHING COMPANYISSN: 2223-3652Frequency: 6 issues/year

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.

SCANDINAVIAN CARDIOVASCULAR JOURNAL

Exploring innovative solutions in cardiovascular medicine.
Publisher: TAYLOR & FRANCIS LTDISSN: 1401-7431Frequency: 6 issues/year

The Scandinavian Cardiovascular Journal, published by Taylor & Francis Ltd, is a distinguished peer-reviewed journal aimed at advancing the field of cardiology and cardiovascular medicine. With an impressive history dating back to 1967 and a forward-looking perspective until 2024, it has consistently contributed valuable research and insights, making it essential reading for anyone involved in cardiovascular healthcare. The journal holds a strong position in the academic community, reflected in its Q2 rating in both Cardiology and Cardiovascular Medicine, and a similar classification in the broader field of Medicine as of 2023. It is indexed in multiple databases, with a Scopus rank of #178 out of 387 in its category, placing it in the 54th percentile. The journal provides open access options, promoting wider dissemination of knowledge while supporting both researchers and practitioners dedicated to improving cardiovascular health. Its focus on high-quality, impactful research makes it an invaluable resource for professionals and students alike, keen to stay at the forefront of cardiology advancements.